Evidence map›Paper›PMID 42627438›Full record

ArticleMolecular biology reports2026

Evaluating the influence of different anticoagulant blood collection tubes on the efficiency of circulating RNA extraction and Real-Time PCR quantification.

Mauro Di Ruvo, Marco Benati, Gian Luca Salvagno, Laura Pighi, Veronica Li Vigni, Sara Visconti, Elisa Paviati, Flavia Sabbatini, Giuseppe Lippi

Abstract read
In one paragraph

Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mauro Di Ruvo *Section of Clinical Biochemistry and School of Medicine, University of Verona, P.le L.Scuro 37134, Verona, Italy. mauro.diruvo@univr.it.ORCID http://orcid.org/0009-0009-8773-0914
Marco Benati *Section of Clinical Biochemistry and School of Medicine, University of Verona, P.le L.Scuro 37134, Verona, Italy.
Gian Luca SalvagnoSection of Clinical Biochemistry and School of Medicine, University of Verona, P.le L.Scuro 37134, Verona, Italy.
Laura PighiSection of Clinical Biochemistry and School of Medicine, University of Verona, P.le L.Scuro 37134, Verona, Italy.
Veronica Li VigniSection of Clinical Biochemistry and School of Medicine, University of Verona, P.le L.Scuro 37134, Verona, Italy.
Sara ViscontiSection of Clinical Biochemistry and School of Medicine, University of Verona, P.le L.Scuro 37134, Verona, Italy.
Elisa PaviatiSection of Clinical Biochemistry and School of Medicine, University of Verona, P.le L.Scuro 37134, Verona, Italy.
Flavia SabbatiniSection of Clinical Biochemistry and School of Medicine, University of Verona, P.le L.Scuro 37134, Verona, Italy.
Giuseppe LippiSection of Clinical Biochemistry and School of Medicine, University of Verona, P.le L.Scuro 37134, Verona, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsRigorous pre-analytical standardization is a prerequisite for reliable use of circulating microRNAs and RNA as clinical biomarkers. This study evaluates the influence of four common anticoagulants (sodium citrate, Dipotassium Ethylenediaminetetraacetic Acid (K2-EDTA), Lithium heparin, and Acid Citrate Dextrose (ACD)) on isolation and quantification of miRNA and RNA from human plasma. MATERIALS AND

methodsFifteen healthy volunteers were recruited from the research staff and donated blood to study the effects of different anticoagulants on molecular tests. After Trizol extraction, we assessed RNA quantification and purity via spectrophotometry and amplification efficiency via Real-Time PCR for miR-133a, cel-miR-39 (exogenous spike-in), and U6snRNA (endogenous control).

resultsOur results confirmed that while K2-EDTA, sodium citrate and ACD provide comparable enzymatic environments for Real-time PCR, lithium heparin strongly inhibited reverse transcriptase and DNA polymerase activity, preventing successful amplification. Furthermore, specific differences in spectrophotometric purity ratios (A

conclusionsFor researchers focusing on circulating RNA and miRNA, sodium citrate, ACD and K2-EDTA should be regarded as suitable anticoagulants, with sodium citrate and ACD offering slightly better spectrophotometric purity profiles. Lithium heparin is strongly discouraged for studies involving enzymatic amplification (PCR), as the Trizol extraction method is insufficient to remove the inhibitory heparin molecules.

Indexed as

AnticoagulantsBlood Specimen CollectionCirculating MicroRNAReal-Time Polymerase Chain ReactionCitratesCitric AcidEdetic AcidFemaleGlucoseHeparinHumansMaleMicroRNAsSodium Citrateacid citrate dextroseAnticoagulantsCirculating MicroRNACitratesCitric AcidEdetic AcidGlucoseHeparinMicroRNAsMIRN133 microRNA, humanSodium CitratemiRNAMolecular biologyPreanalytical variabilityQualityRNA

Identifiers

PMID42627438
PMCPMC13498639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.